Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Immunotherapeutic Potential and In Vivo Targeting of CD33 Splice Variant Isoform

Vivek M. Shastri, Srideshikan Sargur Madabushi, Susanta Hui, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 1394.

https://doi.org/10.1182/blood-2024-208496

Published: 2024

Journal Articles

Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

Francisco Marchi, Ann-Kathrin Schade, Vivek M. Shastri, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Jeffery M Klco, Alan S Gamis, Rhonda E. Ries, Anders Kolb, Richard Aplenc, Todd A. Alonzo, Stanley Pounds, Soheil Meshinchi, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 103.

https://doi.org/10.1182/blood-2024-207665

Published: 2024

Journal Articles

Identification of Interstitial Loss of Heterozygosity (LOH) Regions Flanking CD33 Locus in AML Patients

Vivek M. Shastri, Francisco Marchi, Michael R. Loken, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 1543.

https://doi.org/10.1182/blood-2024-211258

Published: 2024

Journal Articles

Synergistic Effect of Trifluridine and PARPi Combination in Targeting TP53 -Mutated AML

Phani Krishna Parcha, Vivek M. Shastri, Jonathan D. Licht, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 5787.

https://doi.org/10.1182/blood-2024-201781

Published: 2024

Journal Articles

CDKN2A Upregulation Induces Senescence in AML Cell Lines and Leads to Treatment Resistance

Vivek M. Shastri, Nathan Seligson, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 5741.

https://doi.org/10.1182/blood-2024-208173

Published: 2024

Journal Articles

GWAS Identifies Pharmacogenetic Markers Associated with Premedication-Related Pegaspargase Hypersensitivity and Toxicities in Pediatric and Adolescent Young Adults (AYAs) with Acute Lymphoblastic Leukemia or Lymphoma

Vivek M. Shastri, Jennifer Ahmed, Eva Spin, Sonia Morales, Anurag K. Agrawal, Christine L. Phillips, Keith J August, Erin M. Guest, Carol Hwang Lin, Beth Apsel Winger, Catherine Aftandilian, Van Thu Huynh, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 2846.

https://doi.org/10.1182/blood-2024-208260

Published: 2024

Journal Articles

ACS10- Cytarabine Pharmacogenomics Score Impacts Survival in Pediatric AML Patients Treated on AAML1031 Trial and Associates with Outcome Differences in Black AML Patients

Richard J Marrero, Vivek M. Shastri, Richard Aplenc, Todd Cooper, Todd A. Alonzo, Alan S Gamis, Jim Wang, Soheil Meshinchi, E. Anders Kolb, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2023-187515

Published: 2023

Journal Articles

Splicing Polymorphism rs12459419 Modulates Antibody-Bound Internalization of CD33 Isoforms

Vivek M. Shastri, Mohammed O. Gbadamosi, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 5749.

https://doi.org/10.1182/blood-2023-186889

Published: 2023

Journal Articles

Relapse-Enriched Gene Expression Signature of Prognostic Relevance in Pediatric Acute Myeloid Leukemia

Satyavardhan Rao Nittu, Francisco Marchi, Nam Nguyen, Vivek M. Shastri, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Alan S Gamis, E. Anders Kolb, Richard Aplenc, Jeffery Klco, Stanley Pounds, Todd A. Alonzo, Soheil Meshinchi, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 2926.

https://doi.org/10.1182/blood-2023-189029

Published: 2023

Journal Articles

Impact of Cytarabine Pharmacogenomics on Survival of Adolescent and Young Adults with AML and Its Clinical Relevance in Black Patients

Richard J Marrero, Deedra Nicolet, Vivek M. Shastri, Krzysztof Mrózek, Christopher J. Walker, William Blum, Bayard L Powell, Jonathan E Kolitz, Joseph O Moore, Geoffrey L Uy, Wendy Stock, Andrew J Carroll, John C. Byrd, Ann-Kathrin Eisfeld, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 2954.

https://doi.org/10.1182/blood-2023-187361

Published: 2023

Journal Articles

Pharmacogenomics to Predict Asparaginase Premedication-Related Hypersensitivity in Pediatric and Adolescent Young Adults (AYAs) with Acute Lymphoblastic Leukemia or Lymphoma

Vivek M. Shastri, Jennifer Ahmed, Eva Spin, Yeniffer Nunez, Sonia Morales, Anurag Agrawal, Christine L Phillips, Keith J. August, Erin M. Guest, Beth Apsel Winger, Catherine Aftandilian, Van Thu Huynh, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 6067.

https://doi.org/10.1182/blood-2023-187111

Published: 2023

Journal Articles

Pharmacogenomics of Fludarabine in Pediatric HCT Recipients: Preliminary Results

Nam H.K. Nguyen, Vivek M. Shastri, Ying Lu, Beth Apsel Winger, Janel R. Long-Boyle, Biljana N. Horn, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 908.

https://doi.org/10.1182/blood-2021-151457

Published: 2021

Journal Articles

A Polygenic DNA Damage Repair Pharmacogenomics (DDR_PGx8) Score Predicts GO Response in AML

Vivek M. Shastri, Lata Chauhan, Todd A. Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A Hirsch, Alan S. Gamis, Soheil Meshinchi, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 3456.

https://doi.org/10.1182/blood-2021-153181

Published: 2021

Journal Articles

The rs35112940 CD33 Polymorphism Reduces CD33 Internalization and Efficacy of CD33-Directed Gemtuzumab Ozogamicin

Mohammed O Gbadamosi, Vivek M. Shastri, Soheil Meshinchi, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 2247.

https://doi.org/10.1182/blood-2021-150927

Published: 2021

Journal Articles

Pharmacogenomics to Predict Mucositis in Acute Myeloid Leukemia

Jennifer Ahmed, Leila Becirevic, Natasha Emanuel, Molly E. Lofy, Hanh Tran, Vivek M. Shastri, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 2373.

https://doi.org/10.1182/blood-2021-154046

Published: 2021

Journal Articles

Unraveling Subcellular Localization of CD33 Splicing Polymorphism Variant

Vivek M. Shastri, Tiffany A. Hylkema, Mohammed O Gbadamosi, Soheil Meshinchi, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 1290.

https://doi.org/10.1182/blood-2021-153432

Published: 2021

Journal Articles

Pharmacogenomic Single Nucleotide Polymorphism (SNP) Variants As Predictors of Toxicity Phenotypes in the Treatment of Acute Childhood Leukemia

Reema Kashif, Trisha Larkin, Abdelrahman H Elsayed, Nam H.K. Nguyen, Natasha Emanuel, Vivek M. Shastri, Roya Rafiee, Karna Mangrola, Biljana N. Horn, Jatinder K. Lamba

Blood (2021) 138 (Supplement 1): 3360.

https://doi.org/10.1182/blood-2021-151357

Published: 2021

NARROW

Immunotherapeutic Potential and In Vivo Targeting of CD33 Splice Variant Isoform

Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

Identification of Interstitial Loss of Heterozygosity (LOH) Regions Flanking CD33 Locus in AML Patients

Synergistic Effect of Trifluridine and PARPi Combination in Targeting TP53 -Mutated AML

CDKN2A Upregulation Induces Senescence in AML Cell Lines and Leads to Treatment Resistance

GWAS Identifies Pharmacogenetic Markers Associated with Premedication-Related Pegaspargase Hypersensitivity and Toxicities in Pediatric and Adolescent Young Adults (AYAs) with Acute Lymphoblastic Leukemia or Lymphoma

ACS10- Cytarabine Pharmacogenomics Score Impacts Survival in Pediatric AML Patients Treated on AAML1031 Trial and Associates with Outcome Differences in Black AML Patients

Splicing Polymorphism rs12459419 Modulates Antibody-Bound Internalization of CD33 Isoforms

Relapse-Enriched Gene Expression Signature of Prognostic Relevance in Pediatric Acute Myeloid Leukemia

Impact of Cytarabine Pharmacogenomics on Survival of Adolescent and Young Adults with AML and Its Clinical Relevance in Black Patients

Pharmacogenomics to Predict Asparaginase Premedication-Related Hypersensitivity in Pediatric and Adolescent Young Adults (AYAs) with Acute Lymphoblastic Leukemia or Lymphoma

Pharmacogenomics of Fludarabine in Pediatric HCT Recipients: Preliminary Results

A Polygenic DNA Damage Repair Pharmacogenomics (DDR_PGx8) Score Predicts GO Response in AML

The rs35112940 CD33 Polymorphism Reduces CD33 Internalization and Efficacy of CD33-Directed Gemtuzumab Ozogamicin

Pharmacogenomics to Predict Mucositis in Acute Myeloid Leukemia

Unraveling Subcellular Localization of CD33 Splicing Polymorphism Variant

Pharmacogenomic Single Nucleotide Polymorphism (SNP) Variants As Predictors of Toxicity Phenotypes in the Treatment of Acute Childhood Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only